N-(4-boronobenzyl)-2-chloro-N-(2-chloroethyl)-N-methylethan-1-aminium Bromide

ID: ALA5270245

Max Phase: Preclinical

Molecular Formula: C12H19BBrCl2NO2

Molecular Weight: 291.01

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  C[N+](CCCl)(CCCl)Cc1ccc(B(O)O)cc1.[Br-]

Standard InChI:  InChI=1S/C12H19BCl2NO2.BrH/c1-16(8-6-14,9-7-15)10-11-2-4-12(5-3-11)13(17)18;/h2-5,17-18H,6-10H2,1H3;1H/q+1;/p-1

Standard InChI Key:  CLDPLGQICPRPKH-UHFFFAOYSA-M

Molfile:  

     RDKit          2D

 19 18  0  0  0  0  0  0  0  0999 V2000
    1.3934   -1.8502    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
    0.2698   -1.8923    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4445   -2.3048    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4445   -3.1297    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.2698   -1.0673    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.9843   -0.6549    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9843    0.1700    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6946    0.5819    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6946    1.4073    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9825    1.8193    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2677    1.4069    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2677    0.5782    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9825    2.6448    0.0000 B   0  0  0  0  0  0  0  0  0  0  0  0
    0.3151    3.1297    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.6500    3.1297    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5282   -1.2805    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3144   -0.4830    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1113   -0.6964    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6946   -0.1131    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  2  3  1  0
  3  4  1  0
  5  2  1  0
  6  5  1  0
  7  6  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12  7  2  0
 13 10  1  0
 13 14  1  0
 15 13  1  0
  5 16  1  0
  5 17  1  0
 17 18  1  0
 18 19  1  0
M  CHG  2   1  -1   5   1
M  END

Associated Targets(Human)

SR (39847 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H460 (60772 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CAKI-1 (44928 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SN12C (47755 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 291.01Molecular Weight (Monoisotopic): 290.0880AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Wang P, Gong Q, Hu J, Li X, Zhang X..  (2021)  Reactive Oxygen Species (ROS)-Responsive Prodrugs, Probes, and Theranostic Prodrugs: Applications in the ROS-Related Diseases.,  64  (1.0): [PMID:33356214] [10.1021/acs.jmedchem.0c01704]

Source